## Early treatment of acute hepatitis C infection with interferon alfa-2b (IFN -β£-2b) prevents chronicity in almost all patients. So far, no data are available on the long-term outcome after interferon (IFN) therapy of acute hepatitis C. The aim of this study was to assess the clinical, virologica
Immunological, virological and clinical long-term follow-up after interferon therapy of acute hepatitis C infection
β Scribed by J. Wiegand; H.L. Tillmann; E. Jackel; M. Cornberg; M. Dietrich; H. Hinrichsen; W.P. Fritsch; J. Kroger; N. Aslan; A. Kubitschke; M.P. Manns; H. Wedemeyer
- Book ID
- 117372099
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 164 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Clinical relevance of occult hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection(s) remains uncertain years after interferon (IFN) therapy for chronic hepatitis C. By 1993, 38 sustained virological responders (SVRs) showing HCV RNA clearance at 6 months postβtreatment and 3
We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only